Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24596288 | 0.87 | ALDH1A1 (0.35) | ALDH1A1KMT2AKDM4ELMNAGAA | |
| SCHEMBL9004386 | 0.80 | KCNH2 (0.41) | ALDH1A1CNR2 | |
| SCHEMBL21361177 | 0.79 | TLR8 (0.35) | ALDH1A1KMT2AKDM4EHPGDTDP1 | |
| SCHEMBL27770406 | 0.79 | MAPT (0.40) | ALDH1A1KMT2AKDM4EGAAMAPT | |
| SCHEMBL28888928 | 0.75 | TSHR (0.33) | ALDH1A1KMT2ATDP1 | |
| SCHEMBL22431682 | 0.75 | TLR8 (0.35) | ALDH1A1KMT2AHPGDTDP1 | |
| SCHEMBL4636583 | 0.67 | KCNH2 (0.40) | ALDH1A1CNR2 | |
| SCHEMBL18518004 | 0.67 | KDM4E (0.39) | ALDH1A1KDM4ELMNAMAPTHPGD | |
| SCHEMBL23766361 | 0.66 | ALDH1A1 (0.42) | ALDH1A1LMNAHPGDTDP1 | |
| SCHEMBL20922283 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230309389-A1 | CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-09-28 | — | — | US | disclosed |
| US-10008679-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230309389-A1 | CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT EMITTING DEVICE | CRY1, OCIAD1, ORC3 | ALDH1A1 170/4885KMT2A 2492/4885KDM4E 3758/4885 |
| US-10008679-B2 | Organic electroluminescent materials and devices | EPCAM, ICMT, ORAI2 | ALDH1A1 3195/4885KMT2A 3126/4885KDM4E 4373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.